Metropolitan Life Insurance Company (MetLife)’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $5.99K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $5.01K | Hold |
|
|||||
|
2023
Q2 | $10.5K | Hold |
|
|||||
|
2023
Q1 | $11.2K | Sell |
|
|||||
|
2022
Q4 | $9.94K | Buy |
|
|||||
|
2022
Q3 | $12.2K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $79.3K | Buy |
|
|||||
|
2021
Q3 | $93.2K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $96.7K | Hold |
|
|||||
|
2019
Q1 | $85.5K | Buy |
|
|||||
|
2018
Q4 | $98K | Hold |
|
|||||
|
2018
Q3 | $157K | Hold |
|
|||||
|
2018
Q2 | $177K | Hold |
|
|||||
|
2018
Q1 | $126K | Hold |
|
|||||
|
2017
Q4 | $146K | Sell |
|
|||||
|
2017
Q3 | $408K | Hold |
|
|||||
|
2017
Q2 | $546K | Hold |
|
|||||
|
2017
Q1 | $476K | Sell |
|
|||||
|
2016
Q4 | $472K | Hold |
|
|||||
|
2016
Q3 | $617K | Hold |
|
|||||
|
2016
Q2 | $490K | Hold |
|
|||||
|
2016
Q1 | $408K | Hold |
|
|||||
|
2015
Q4 | $454K | Buy |
|
|||||
|
2015
Q3 | $295K | Buy |
|
|||||
|
2015
Q2 | $183K | Sell |
|
|||||
|
2015
Q1 | $180K | Buy |
|
|||||
|
2014
Q4 | $172K | Hold |
|
|||||
|
2014
Q3 | $266K | Buy |
|
|||||
|
2014
Q2 | $165K | Sell |
|
|||||
|
2014
Q1 | $317K | Sell |
|
|||||
|
2013
Q4 | $340K | Hold |
|
|||||
|
2013
Q3 | $448K | Buy |
|
|||||
|
2013
Q2 | $250K | Buy |
|